Breaking News Instant updates and real-time market news.

HMSVF

Homeserve

$15.25 /

+ (+0.00%)

07:00
06/07/21
06/07
07:00
06/07/21
07:00

Homeserve assumed with an Outperform at Credit Suisse

Credit Suisse analyst Andy Grobler assumed coverage of Homeserve with an Outperform rating and 1,100 GBp price target. The analyst made no changes to the firm's prior rating or target.

HMSVF Homeserve
$15.25 /

+ (+0.00%)

05/19/21 JPMorgan
Homeserve price target lowered to 1,215 GBp from 1,261 GBp at JPMorgan
11/23/20 RBC Capital
Homeserve price target raised to 1,300 GBp from 1,200 GBp at RBC Capital
11/18/20 JPMorgan
Homeserve price target raised to 1,410 GBp from 1,400 GBp at JPMorgan
11/05/20 Credit Suisse
Homeserve initiated with an Outperform at Credit Suisse

TODAY'S FREE FLY STORIES

Earnings
FireEye reports Q2 EPS (14c), consensus 9c » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
FEYE

FireEye

$20.11 /

-0.35 (-1.71%)

Reports Q2 revenue $114M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

07/16/21 Mizuho
FireEye price target lowered to $21 from $23 at Mizuho
07/08/21 Barclays
FireEye price target lowered to $20 from $22 at Barclays
06/03/21 Baird
FireEye rebranding reduces financial visibility, says Baird
06/03/21 Morgan Stanley
FireEye break up makes sense, but upside 'less clear,' says Morgan Stanley
FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

Earnings
Alarm.com reports Q2 adjusted EPS 54c, consensus 39c » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
ALRM

Alarm.com

$85.37 /

+0.87 (+1.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Alarm.com initiated with an Equal Weight at Barclays
04/08/21 Imperial Capital
Alarm.com price target raised to $105 from $100 at Imperial Capital
04/06/21 JPMorgan
Alarm.com initiated with a Neutral at JPMorgan
ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

Earnings
Cornerstone OnDemand reports Q2 EPS 73c , consensus 52c » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
CSOD

Cornerstone OnDemand

$49.94 /

+0.46 (+0.93%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

06/30/21 Berenberg
Cornerstone OnDemand initiated with a Buy at Berenberg
05/07/21 BMO Capital
Cornerstone OnDemand price target lowered to $50 from $63 at BMO Capital
04/27/21 JMP Securities
Workday price target raised to $310 from $296 at JMP Securities
03/26/21 DA Davidson
DA Davidson sees 'material' COVID tailwinds for Cornerstone OnDemand
CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

Hot Stocks
Expedia reports Q2 gross bookings $20.82B, up 667% y/y  16:03
08/05/21
08/05
16:03
08/05/21
16:03
EXPE

Expedia

$161.09 /

+7.8 (+5.09%)

 
ShowHide Related Items >><<
EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

05/26/21 RBC Capital
Expedia assumed with a Sector Perform at RBC Capital
05/12/21 Citi
Expedia price target raised to $179 from $160 at Citi
05/07/21 BTIG
Expedia price target raised to $210 from $180 at BTIG
05/07/21 Credit Suisse
Expedia price target raised to $198 from $168 at Credit Suisse
EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

Hot Stocks
OpenText raises dividend 10% to 22.09c per share » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
OTEX

OpenText

$52.15 /

+0.545 (+1.06%)

The record date for this…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTEX OpenText
$52.15 /

+0.545 (+1.06%)

06/30/21 Barclays
OpenText downgraded to Equal Weight from Overweight at Barclays
02/05/21 Barclays
OpenText price target raised to $55 from $51 at Barclays
08/10/20 Veritas
OpenText downgraded to Sell from Buy at Veritas
OTEX OpenText
$52.15 /

+0.545 (+1.06%)

Earnings
Cytokinetics sees FY21 revenue $23M-$28M, consensus $10.18M » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
CYTK

Cytokinetics

$29.95 /

+0.45 (+1.53%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$29.95 /

+0.45 (+1.53%)

CYTK Cytokinetics
$29.95 /

+0.45 (+1.53%)

07/20/21 Cantor Fitzgerald
Cytokinetics price target raised to $48 from $35 at Cantor Fitzgerald
07/20/21 Barclays
Cytokinetics price target raised to $40 from $28 at Barclays
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
07/19/21 Raymond James
Cytokinetics price target raised to $54 from $37 at Raymond James
CYTK Cytokinetics
$29.95 /

+0.45 (+1.53%)

  • 21
    Jul
CYTK Cytokinetics
$29.95 /

+0.45 (+1.53%)

Hot Stocks
Dicerna reports 'positive' top-line results from PHYOX 2 trial » 16:02
08/05/21
08/05
16:02
08/05/21
16:02
DRNA

Dicerna

$37.76 /

+0.51 (+1.37%)

Dicerna positive top-line…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRNA Dicerna
$37.76 /

+0.51 (+1.37%)

DRNA Dicerna
$37.76 /

+0.51 (+1.37%)

06/25/21 B. Riley
Dicerna price target raised to $49 from $40 at B. Riley
06/23/21 H.C. Wainwright
Dicerna price target raised to $42 from $40 at H.C. Wainwright
05/27/21 H.C. Wainwright
H.C. Wainwright bullish on Dicerna as new RNAi candidate enters clinic
04/19/21 Truist
Dicerna price target raised to $45 from $35 at Truist
DRNA Dicerna
$37.76 /

+0.51 (+1.37%)

DRNA Dicerna
$37.76 /

+0.51 (+1.37%)

Earnings
Expedia reports Q2 adjusted EPS ($1.13), consensus (65c) » 16:02
08/05/21
08/05
16:02
08/05/21
16:02
EXPE

Expedia

$160.94 /

+7.65 (+4.99%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPE Expedia
$160.94 /

+7.65 (+4.99%)

EXPE Expedia
$160.94 /

+7.65 (+4.99%)

05/26/21 RBC Capital
Expedia assumed with a Sector Perform at RBC Capital
05/12/21 Citi
Expedia price target raised to $179 from $160 at Citi
05/07/21 BTIG
Expedia price target raised to $210 from $180 at BTIG
05/07/21 Credit Suisse
Expedia price target raised to $198 from $168 at Credit Suisse
EXPE Expedia
$160.94 /

+7.65 (+4.99%)

EXPE Expedia
$160.94 /

+7.65 (+4.99%)

EXPE Expedia
$160.94 /

+7.65 (+4.99%)

EXPE Expedia
$160.94 /

+7.65 (+4.99%)

Earnings
OpenText reports Q4 adjusted EPS 80c, consensus 71c » 16:02
08/05/21
08/05
16:02
08/05/21
16:02
OTEX

OpenText

$52.15 /

+0.545 (+1.06%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTEX OpenText
$52.15 /

+0.545 (+1.06%)

06/30/21 Barclays
OpenText downgraded to Equal Weight from Overweight at Barclays
02/05/21 Barclays
OpenText price target raised to $55 from $51 at Barclays
08/10/20 Veritas
OpenText downgraded to Sell from Buy at Veritas
OTEX OpenText
$52.15 /

+0.545 (+1.06%)

Earnings
Cytokinetics reports Q2 EPS (86c), consensus (65c) » 16:01
08/05/21
08/05
16:01
08/05/21
16:01
CYTK

Cytokinetics

$29.97 /

+0.47 (+1.59%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$29.97 /

+0.47 (+1.59%)

CYTK Cytokinetics
$29.97 /

+0.47 (+1.59%)

07/20/21 Cantor Fitzgerald
Cytokinetics price target raised to $48 from $35 at Cantor Fitzgerald
07/20/21 Barclays
Cytokinetics price target raised to $40 from $28 at Barclays
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
07/19/21 Raymond James
Cytokinetics price target raised to $54 from $37 at Raymond James
CYTK Cytokinetics
$29.97 /

+0.47 (+1.59%)

  • 21
    Jul
CYTK Cytokinetics
$29.97 /

+0.47 (+1.59%)

Earnings
Arrowhead reports Q3 EPS (29c), consensus (20c) » 16:01
08/05/21
08/05
16:01
08/05/21
16:01
ARWR

Arrowhead

$67.86 /

+1.82 (+2.76%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARWR Arrowhead
$67.86 /

+1.82 (+2.76%)

ARWR Arrowhead
$67.86 /

+1.82 (+2.76%)

07/06/21 Piper Sandler
Arrowhead renal cell carcinoma data 'encouraging,' says Piper Sandler
07/02/21 H.C. Wainwright
Arrowhead selloff brings 'compelling buying opportunity,' says H.C. Wainwright
07/02/21 RBC Capital
RBC trims Arrowhead target to $83, but says ENaC pause 'not thesis changing'
07/02/21 B. Riley
Arrowhead selloff presents buying opportunity, says B. Riley
ARWR Arrowhead
$67.86 /

+1.82 (+2.76%)

ARWR Arrowhead
$67.86 /

+1.82 (+2.76%)

Earnings
Beacon Roofing reports Q3 EPS 91c, consensus $1.30 » 16:01
08/05/21
08/05
16:01
08/05/21
16:01
BECN

Beacon Roofing

$53.94 /

+0.46 (+0.86%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BECN Beacon Roofing
$53.94 /

+0.46 (+0.86%)

BECN Beacon Roofing
$53.94 /

+0.46 (+0.86%)

07/15/21 Wells Fargo
Beacon Roofing initiated with an Equal Weight at Wells Fargo
07/15/21 Baird
Beacon Roofing price target raised to $66 from $65
07/15/21 Baird
Beacon Roofing price target raised to $66 from $65
05/07/21 Truist
Beacon Roofing price target raised to $68 from $49 at Truist
BECN Beacon Roofing
$53.94 /

+0.46 (+0.86%)

BECN Beacon Roofing
$53.94 /

+0.46 (+0.86%)

Hot Stocks
Cornerstone OnDemand trading halted, news pending  16:00
08/05/21
08/05
16:00
08/05/21
16:00
CSOD

Cornerstone OnDemand

$49.96 /

+0.48 (+0.97%)

 
ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$49.96 /

+0.48 (+0.97%)

CSOD Cornerstone OnDemand
$49.96 /

+0.48 (+0.97%)

06/30/21 Berenberg
Cornerstone OnDemand initiated with a Buy at Berenberg
05/07/21 BMO Capital
Cornerstone OnDemand price target lowered to $50 from $63 at BMO Capital
04/27/21 JMP Securities
Workday price target raised to $310 from $296 at JMP Securities
03/26/21 DA Davidson
DA Davidson sees 'material' COVID tailwinds for Cornerstone OnDemand
CSOD Cornerstone OnDemand
$49.96 /

+0.48 (+0.97%)

CSOD Cornerstone OnDemand
$49.96 /

+0.48 (+0.97%)

Hot Stocks
Dicerna trading halted, news pending  16:00
08/05/21
08/05
16:00
08/05/21
16:00
DRNA

Dicerna

$37.70 /

+0.445 (+1.19%)

 
ShowHide Related Items >><<
DRNA Dicerna
$37.70 /

+0.445 (+1.19%)

DRNA Dicerna
$37.70 /

+0.445 (+1.19%)

06/25/21 B. Riley
Dicerna price target raised to $49 from $40 at B. Riley
06/23/21 H.C. Wainwright
Dicerna price target raised to $42 from $40 at H.C. Wainwright
05/27/21 H.C. Wainwright
H.C. Wainwright bullish on Dicerna as new RNAi candidate enters clinic
04/19/21 Truist
Dicerna price target raised to $45 from $35 at Truist
DRNA Dicerna
$37.70 /

+0.445 (+1.19%)

DRNA Dicerna
$37.70 /

+0.445 (+1.19%)

Conference/Events
Seabridge Gold participates in a webinar » 15:55
08/05/21
08/05
15:55
08/05/21
15:55
SA

Seabridge Gold

$17.95 /

-0.05 (-0.28%)

Town Hall Webinar is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SA Seabridge Gold
$17.95 /

-0.05 (-0.28%)

SA Seabridge Gold
$17.95 /

-0.05 (-0.28%)

12/14/20 B. Riley Securities
Seabridge Gold price target raised to $109 from $96 at B. Riley Securities
09/03/20 B. Riley FBR
Seabridge Gold assumed with a Buy at B. Riley FBR
Recommendations
Piper Sandler would remain buyers of Change Healthcare » 15:51
08/05/21
08/05
15:51
08/05/21
15:51
CHNG

Change Healthcare

$21.19 /

+0.3 (+1.44%)

, UNH

UnitedHealth

$410.60 /

-11.01 (-2.61%)

After Change Healthcare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHNG Change Healthcare
$21.19 /

+0.3 (+1.44%)

UNH UnitedHealth
$410.60 /

-11.01 (-2.61%)

CHNG Change Healthcare
$21.19 /

+0.3 (+1.44%)

07/28/21 SVB Leerink
Inovalon price target raised to $45 from $35 at SVB Leerink
04/29/21 JPMorgan
Change Healthcare assumed with a Neutral at JPMorgan
02/10/21 JPMorgan
Change Healthcare downgraded to Neutral on buyout at JPMorgan
02/10/21 JPMorgan
Change Healthcare downgraded to Neutral from Overweight at JPMorgan
UNH UnitedHealth
$410.60 /

-11.01 (-2.61%)

07/28/21 SVB Leerink
Inovalon price target raised to $45 from $35 at SVB Leerink
07/21/21 BofA
BofA ups Peloton target to $135 from $123 on UnitedHealth partnership
07/16/21 Stephens
UnitedHealth price target raised to $460 from $440 at Stephens
07/16/21 Raymond James
UnitedHealth price target raised to $515 from $435 at Raymond James
CHNG Change Healthcare
$21.19 /

+0.3 (+1.44%)

UNH UnitedHealth
$410.60 /

-11.01 (-2.61%)

  • 07
    Aug
CHNG Change Healthcare
$21.19 /

+0.3 (+1.44%)

UNH UnitedHealth
$410.60 /

-11.01 (-2.61%)

CHNG Change Healthcare
$21.19 /

+0.3 (+1.44%)

UNH UnitedHealth
$410.60 /

-11.01 (-2.61%)

UNH UnitedHealth
$410.60 /

-11.01 (-2.61%)

Options
Newegg Commerce Inc call volume above normal and directionally bullish » 15:45
08/05/21
08/05
15:45
08/05/21
15:45
NEGG

Newegg Commerce

$20.67 /

+3.88 (+23.11%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEGG Newegg Commerce
$20.67 /

+3.88 (+23.11%)

NEGG Newegg Commerce
$20.67 /

+3.88 (+23.11%)

NEGG Newegg Commerce
$20.67 /

+3.88 (+23.11%)

NEGG Newegg Commerce
$20.67 /

+3.88 (+23.11%)

Recommendations
Regeneron price target raised to $675 from $650 at Piper Sandler » 15:43
08/05/21
08/05
15:43
08/05/21
15:43
REGN

Regeneron

$599.48 /

+19.3 (+3.33%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$599.48 /

+19.3 (+3.33%)

REGN Regeneron
$599.48 /

+19.3 (+3.33%)

08/02/21 H.C. Wainwright
Regeneron price target raised to $741 from $729 at H.C. Wainwright
07/29/21 H.C. Wainwright
Regeneron price target raised to $729 from $703 at H.C. Wainwright
07/23/21 RBC Capital
Regeneron price target raised to $679 from $629 at RBC Capital
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
REGN Regeneron
$599.48 /

+19.3 (+3.33%)

REGN Regeneron
$599.48 /

+19.3 (+3.33%)

REGN Regeneron
$599.48 /

+19.3 (+3.33%)

REGN Regeneron
$599.48 /

+19.3 (+3.33%)

Hot Stocks
Hywin Holdings Ltd (ADS) trading resumes  15:35
08/05/21
08/05
15:35
08/05/21
15:35
HYW

Hywin Holdings

$5.70 /

+0.05 (+0.88%)

 
ShowHide Related Items >><<
HYW Hywin Holdings
$5.70 /

+0.05 (+0.88%)

HYW Hywin Holdings
$5.70 /

+0.05 (+0.88%)

  • 26
    Mar
HYW Hywin Holdings
$5.70 /

+0.05 (+0.88%)

Options
Kadmon options imply 28.6% move in share price post-earnings » 15:34
08/05/21
08/05
15:34
08/05/21
15:34
KDMN

Kadmon

$4.62 /

+0.02 (+0.43%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KDMN Kadmon
$4.62 /

+0.02 (+0.43%)

KDMN Kadmon
$4.62 /

+0.02 (+0.43%)

07/19/21 Jefferies
Kadmon price target raised to $10 from $9 at Jefferies
06/04/21 Mizuho
Kadmon's KD022 results a positive start for immuno-oncology program, says Mizuho
05/20/21 UBS
Kadmon initiated with a Buy at UBS
03/11/21 Oppenheimer
Kadmon should be bought on weakness from FDA extension, says Oppenheimer
KDMN Kadmon
$4.62 /

+0.02 (+0.43%)

Recommendations
GoDaddy price target lowered to $100 from $108 at JMP Securities » 15:31
08/05/21
08/05
15:31
08/05/21
15:31
GDDY

GoDaddy

$72.04 /

-11.415 (-13.68%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDDY GoDaddy
$72.04 /

-11.415 (-13.68%)

GDDY GoDaddy
$72.04 /

-11.415 (-13.68%)

09:56 Today
Fly Intel: Top five analyst downgrades
08:13 Today Wedbush
GoDaddy price target lowered to $92 from $108 at Wedbush
07:31 Today Rosenblatt
GoDaddy downgraded to Neutral on 'meaningful' reset at Rosenblatt
07:26 Today Rosenblatt
GoDaddy downgraded to Neutral from Buy at Rosenblatt
GDDY GoDaddy
$72.04 /

-11.415 (-13.68%)

GDDY GoDaddy
$72.04 /

-11.415 (-13.68%)

Hot Stocks
Hywin Holdings Ltd (ADS) trading halted, volatility trading pause  15:30
08/05/21
08/05
15:30
08/05/21
15:30
HYW

Hywin Holdings

$5.70 /

+0.05 (+0.88%)

 
ShowHide Related Items >><<
HYW Hywin Holdings
$5.70 /

+0.05 (+0.88%)

  • 26
    Mar
HYW Hywin Holdings
$5.70 /

+0.05 (+0.88%)

Downgrade
MorphoSys downgraded to Hold from Buy at Deutsche Bank » 15:29
08/05/21
08/05
15:29
08/05/21
15:29
MOR

MorphoSys

$13.82 /

+0.38 (+2.83%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MOR MorphoSys
$13.82 /

+0.38 (+2.83%)

MOR MorphoSys
$13.82 /

+0.38 (+2.83%)

08/04/21 Morgan Stanley
MorphoSys price target lowered to EUR 75 from EUR 86 at Morgan Stanley
08/04/21 JPMorgan
MorphoSys price target lowered to EUR 54 from EUR 80 at JPMorgan
07/27/21 SVB Leerink
MorphoSys price target lowered to EUR 96 from EUR 106 at SVB Leerink
07/27/21 Commerzbank
MorphoSys downgraded to Hold from Buy at Commerzbank
MOR MorphoSys
$13.82 /

+0.38 (+2.83%)

MOR MorphoSys
$13.82 /

+0.38 (+2.83%)

Options
Asensus Surgical options imply 18.9% move in share price post-earnings » 15:19
08/05/21
08/05
15:19
08/05/21
15:19
ASXC

Asensus Surgical

$2.36 /

+0.055 (+2.39%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASXC Asensus Surgical
$2.36 /

+0.055 (+2.39%)

ASXC Asensus Surgical
$2.36 /

+0.055 (+2.39%)

05/26/21 H.C. Wainwright
Asensus Surgical initiated with a Buy at H.C. Wainwright
ASXC Asensus Surgical
$2.36 /

+0.055 (+2.39%)

ASXC Asensus Surgical
$2.36 /

+0.055 (+2.39%)

ASXC Asensus Surgical
$2.36 /

+0.055 (+2.39%)

Recommendations
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler » 15:17
08/05/21
08/05
15:17
08/05/21
15:17
JNCE

Jounce Therapeutics

$5.26 /

+0.13 (+2.53%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

  • 10
    Mar
JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.